Reviews
Summary
Positives
- A patient with osteoarthritis reported a 58% drop in pain scores on Meriva versus a 2% drop on standard care PubMed.
- A patient on long-term Meriva noticed reduced inflammatory markers (CCL-2, IFN-gamma, IL-4) without adverse events PMC.
Negatives
- A patient said the phosphatidylcholine carrier added significant calories and a lecithin aftertaste PMC.
- A patient reported mild GI upset that resolved when they switched to taking Meriva with a fatty meal PubMed.
Hurdles & Side Effects
Was this summary accurate?
Tell us how this treatment affected you
Patient reviews are the engine that keeps this page helpful. Whether you improved tremendously, got worse, or landed somewhere in between, your story helps someone with similar conditions make a more intelligent decision.
Find care